Can AI Finally End Delays in Cancer Care? Viz.ai and Novartis Think So
Delays in cancer diagnosis and treatment are costing lives and fueling frustration. But two industry giants say artificial intelligence could be the breakthrough medicine has been waiting for. Can AI-powered tools finally connect patients to care at the speed—and accuracy—they desperately need? Let’s dive in.
⏳ The Costly